Skip to main content

Indian Pharma Network

Roflumilast Cream

  • Medicine Name: Roflumilast Cream
  • Active Ingredient (API): Roflumilast
  • Dosage Form & Strength: Cream: 0.3%
  • Manufactured By: Arcutis Biotherapeutics (marketed as Zoryve)

Medical Uses

Roflumilast cream 0.3% (marketed as Zoryve), from Arcutis Biotherapeutics, is indicated for the topical treatment of plaque psoriasis, including intertriginous areas, in patients 6 years of age and older.

Roflumilast is a phosphodiesterase-4 (PDE4) inhibitor. By inhibiting PDE4, it reduces the production of pro-inflammatory cytokines in skin cells, helping to reduce the redness, thickness, and scaling of psoriasis plaques.

Warnings & Precautions

  • Application-site reactions such as burning, stinging, or pain may occur.
  • Diarrhea, headache, nausea, and upper respiratory tract infection have been reported.
  • For topical use only — avoid contact with eyes, mouth, and vaginal areas.
  • Some formulations may increase the risk of certain psychiatric symptoms; discuss any mood changes with your physician.

Documentation & Availability

What documents are required to import Roflumilast Cream to India?

Roflumilast cream may be imported in the patient’s name only, by patients or government hospitals. The following documentation is required:

  • A valid prescription from a registered dermatologist
  • Patient ID proof (issued by the Government of India)
How is the order confirmed?

The order is confirmed only after receipt and verification of a valid prescription.

Is Roflumilast Cream available in India?

Roflumilast cream is not commercially marketed in India. It can be legally accessed through the Named Patient Program (NPP).

Sourcing & Delivery

Indian Pharma Network (IPN) can source Roflumilast cream from its authorized distribution network and facilitate supply to patients, doctors, and hospitals under applicable legal provisions.

For cost in India and availability, contact IPN at Phone: +91-9310090915 or email info@indianpharmanetwork.in.

Global Approval Status:

  • United States: Approved by the FDA (as Zoryve) — July 2022.

FAQ

What is Roflumilast Cream used for?

Roflumilast cream treats plaque psoriasis, including sensitive intertriginous skin areas, in patients 6 and older.

Who manufactures Roflumilast Cream?

Roflumilast cream is developed by Arcutis Biotherapeutics, marketed as Zoryve.

How is Roflumilast Cream applied?

Applied topically to affected skin areas once daily, as directed by the treating dermatologist.

How much does Roflumilast Cream cost in India?

Cost depends on tube size and sourcing logistics — share your prescription with IPN for a quote.

Contact Patient Support

If you have any questions or need any help, contact our Patient Support Team. We will get in touch with you within 24 hours from Monday to Friday between 9:00 and 10:00 CET.

Disclaimer

All Trademarks and Brands that appear on the website belong to their respective owners and indianpharmanetwork does not lay any claim on them we only provide Information.

Product Enquiry